Key Takeaways A three-year study of tirzepatide—the active ingredient in Eli Lilly’s injectable weight-loss drug…
Tag:
Lilly
-
-
BusinessHealth CareNews
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
by adminAn Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New…
-
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg |…
-
Mutual FundsNews
Eli Lilly Stock Finishes Lower After News of Bond Sale to Fund Morphic Deal
by adminKey Takeaways Eli Lilly is selling bonds to fund the acquisition of drug developer Morphic.…
-
Key Takeaways It was a second straight day of gains for Eli Lilly shares following…
-
- 1
- 2